RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) ...

Viking Therapeutics (NASDAQ: VKTX) and Novavax (NASDAQ: NVAX) were two of the big winners in the biotech industry last year.

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the ...

Moderna (MRNA) announced that the Medicines and Healthcare products Regulatory Agency in the UK has granted marketing authorization for ...

Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...

2-Year U.S. Treasury Note Continuous Contract $103.371 0.277 0.27% 5-Year U.S. Treasury Note Continuous Contract $107.711 0.188 0.17% 10-Year U.S. Treasury Note Continuous Contract $110.828-0.063 ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...